Bryant E. Fong

Managing Director

Prior to joining Burrill & Company in 1998, Mr. Fong held positions as a biochemist and molecular biologist with two early-stage biotechnology companies located in the San Francisco Bay Area. His research experiences include recombinant protein expression in yeast, development of linear artificial chromosomes, and catalytic RNA technology.

Mr. Fong earned his bachelors degree with distinction and honors in Molecular and Cell Biology-Biochemistry from the University of California, Berkeley.

Mr. Fong currently serves on the Boards of Directors of FerroKin Biosciences, Nora Therapeutics, Neurotech Pharmaceuticals, Odyssey Thera, TRF Pharma, and Logical Therapeutics (observer).